References
- Matsushita K, Ding N, Kou M, et al. The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis. Glob Heart. 2020;15(1):64. doi:10.5334/gh.814
- Katsoularis I, Fonseca-Rodríguez O, Farrington P, Lindmark K, Connolly A-MF. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599–607. doi:10.1016/S0140-6736(21)00896-5
- Modin D, Claggett B, Sindet-Pedersen C, et al. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142(21):2080–2082.
- Ho FK, Man KKC, Toshner M, et al. Thromboembolic risk in hospitalized and nonhospitalized COVID-19 patients: a self-controlled case series analysis of a nationwide cohort. Mayo Clin Proc. 2021;96(10):2587–2597. doi:10.1016/j.mayocp.2021.07.002
- Long B, Brady WJ, Koyfman A, Gottlieb M. Cardiovascular complications in COVID-19. Am J Emerg Med. 2020;38(7):1504–1507. doi:10.1016/j.ajem.2020.04.048
- Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. 2022;28(3):583. doi:10.1038/s41591-022-01689-3
- Thakkar S, Arora S, Kumar A, et al. A systematic review of the cardiovascular manifestations and outcomes in the setting of coronavirus-19 disease. Clin Med Insights Cardiol. 2020;14:1179546820977196.
- Augustine R, Abhilash S, Nayeem A, et al. Increased complications of COVID-19 in people with cardiovascular disease: role of the renin–angiotensin-aldosterone system (RAAS) dysregulation. Chem Biol Interact. 2022;351:109738. doi:10.1016/j.cbi.2021.109738
- Majure DT, Gruberg L, Saba SG, Kvasnovsky C, Hirsch JS, Jauhar R. Usefulness of elevated troponin to predict death in patients with COVID-19 and myocardial injury. Am J Cardiol. 2021;138:100–106. doi:10.1016/j.amjcard.2020.09.060
- Lippi G, Lavie CJ, Sanchis-Gomar F. Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): evidence from a meta-analysis. Prog Cardiovasc Dis. 2020;63(3):390–391. doi:10.1016/j.pcad.2020.03.001
- Tersalvi G, Vicenzi M, Calabretta D, Biasco L, Pedrazzini G, Winterton D. Elevated troponin in patients with coronavirus disease 2019: possible mechanisms. J Card Fail. 2020;26(6):470–475. doi:10.1016/j.cardfail.2020.04.009
- Srivastava A, Rockman-Greenberg C, Sareen N, Lionetti V, Dhingra S. An insight into the mechanisms of COVID-19, SARS-CoV2 infection severity concerning β-cell survival and cardiovascular conditions in diabetic patients. Mol Cell Biochem. 2022;477(6):1681–1695. doi:10.1007/s11010-022-04396-2
- Sabatino J, Rosa S, Di Salvo G, Indolfi C. Impact of cardiovascular risk profile on COVID-19 outcome. A meta-analysis. Ricottini E, ed. PLoS One. 2020;15(8):e0237131. doi:10.1371/journal.pone.0237131
- NHS Digital. COVID-19 population risk assessment - NHS digital. Available from: https://digital.nhs.uk/coronavirus/risk-assessment/population. Accessed July 10, 2022.
- Whitaker HJ, Ghebremichael-Weldeselassie Y, Douglas IJ, Smeeth L, Farrington CP. Investigating the assumptions of the self-controlled case series method. Stat Med. 2018;37(4):643–658. doi:10.1002/sim.7536
- Public Health England. COVID-19 Hospitalisation in England Surveillance System (CHESS) – daily reporting. Available from: https://www.england.nhs.uk/coronavirus/wp-content/uploads/sites/52/2020/03/phe-letter-to-trusts-re-daily-covid-19-hospital-surveillance-11-march-2020.pdf. Accessed August 23, 2023.
- Davidson J, Warren-Gash C, Banerjee A, McDonald H, Smeeth L. London school of hygiene and tropical medicine data compass. Codelists. Available from: https://datacompass.lshtm.ac.uk/id/eprint/2675/. Accessed January 14, 2022.
- Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ. 2009;339(jul07 2):144–147. doi:10.1136/bmj.b2584
- Hippisley-Cox J, Coupland C, Brindle P. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study. BMJ. 2017;357:j2099. doi:10.1136/bmj.j2099
- Davidson J, Strongman H, Herrett E, Gadd S. qrisk_cprd_aurum: QRISK aurum bundle version 2.0; 2022.
- ClinRisk Ltd. QRISK3 algorithm. Available from: https://qrisk.org/three/src.php. Accessed August 23, 2023.
- Office from National Statistics. Coronavirus (COVID-19) infection survey technical article: waves and lags of COVID-19 in England; 2021. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19infectionsurveytechnicalarticle/wavesandlagsofcovid19inenglandjune2021. Accessed October 27, 2021.
- Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611–2618. doi:10.1056/NEJMoa041747
- Warren-Gash C, Hayward AC, Hemingway H, et al. Influenza infection and risk of acute myocardial infarction in England and Wales: a CALIBER Self-Controlled Case Series Study. J Infect Dis. 2012;206(11):1652–1659. doi:10.1093/infdis/jis597
- Warren-Gash C, Blackburn R, Whitaker H, McMenamin J, Hayward AC. Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland. Eur Respir J. 2018;51(3):1701794. doi:10.1183/13993003.01794-2017
- Davidson JA, Banerjee A, Smeeth L, et al. Risk of acute respiratory infection and acute cardiovascular events following acute respiratory infection among adults with increased cardiovascular risk in England between 2008 and 2018: a retrospective, population-based cohort study. Lancet Digit Health. 2021;3(12):e773–e783. doi:10.1016/S2589-7500(21)00203-X
- Public Health England. Influenza: the green book. Chapter19. Available from: https://www.gov.uk/government/publications/influenza-The-green-book-chapter-19. Accessed December 3, 2020.
- Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543–558. doi:10.1038/s41569-020-0413-9
- Poznyak AV, Bezsonov EE, Eid AH, et al. ACE2 is an adjacent element of atherosclerosis and COVID-19 pathogenesis. Int J Mol Sci. 2021;22(9):4691. doi:10.3390/ijms22094691
- Mohamed MO, Banerjee A. Long COVID and cardiovascular disease: a learning health system approach. Nat Rev Cardiol. 2022;19(5):287–288. doi:10.1038/s41569-022-00697-7
- Wolf A, Dedman D, Campbell J, et al. Data resource profile: Clinical Practice Research Datalink (CPRD) aurum. Int J Epidemiol. 2019;48(6):1740–1740g. doi:10.1093/ije/dyz034
- Ball S, Banerjee A, Berry C, et al. Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK. Heart. 2020;106(24):1890–1897. doi:10.1136/heartjnl-2020-317870